Skip to main content
  • Poster presentation
  • Open access
  • Published:

Neurally adjusted ventilatory assist reduces asynchrony and patient effort in severe acute respiratory distress syndrome patients undergoing extracorporeal membrane oxygenation

Introduction

Assisted ventilation may prevent muscle atrophy and reduce sedation needs in severe acute respiratory distress syndrome (ARDS) patients undergoing extracorporeal membrane oxygenation (ECMO). However, pressure support (PS) is difficult to implement in these patients: inspiratory flow peaks and drops rapidly and the ventilator expiratory phase may overlap patient inspiration causing asynchrony and barotrauma. Neurally adjusted ventilatory assist (NAVA) is an assisted ventilation mode driven by diaphragmatic electrical activity (EAdi) and should adapt better to patients' respiratory pattern. We measured whether NAVA could reduce asynchrony in severe ARDS patients undergoing ECMO.

Methods

We enrolled seven consecutive adult patients undergoing ECMO for severe ARDS. Twenty-four hours after their ventilation mode was switched from controlled to assisted, we randomly tested the following strategies for 30 minutes each, leaving positive end-expiratory pressure (PEEP), FiO2 and ECMO settings unchanged: (1) PS with expiratory trigger at 30% of flow peak value (PS30); (2) PS with expiratory trigger at 1% (PS1); (3) NAVA. The PS level and NAVA gain were chosen to obtain a similar tidal volume (VT). From continuous recordings of airway pressure, flow, volumes and EAdi we calculated the average VT, respiratory rate (RR) and asynchrony index (AI: number of asynchrony events/(ventilator cycles + wasted efforts) × 100) of each step and, at the end, we measured arterial blood gases and p0.1. Data are the median (IQR) and were compared by nonparametric Friedman test and linear regression.

Results

At enrolment, patients were 44 (42 to 56) years old. Respiratory system compliance (Crs) was 12 (9 to 23) ml/cmH2O, PEEP 10 (7 to 12) cmH2O, FiO2 0.5 (0.4 to 0.5) and VT 2.9 (2.8 to 4) ml/kg. Patients were on 3.2 (2.9 to 3.6) l/minute venovenous ECMO since 22 (16 to 29) days. Switching from PS30 to PS1 to NAVA, PaO2/FiO2 did not change (P = 0.817), p0.1 was reduced (3.1 (2.6 to 5.7) vs. 2.1 (1.8 to 3.2) vs. 1.6 (0.9 to 2.3) cmH2O, P = 0.003) together with RR (P = 0.129) and AI (55 (29 to 66) vs. 46 (26 to 56) vs. 16 (8 to 18)%, P = 0.004). The difference between AI during PS30 and NAVA was significantly correlated with Crs (R2 = 0.87, P = 0.02).

Conclusions

Implementation of NAVA in severe ARDS patients undergoing ECMO may decrease patient effort and asynchrony events. The advantage of NAVA over PS is more evident in patients with lower Crs.

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Mauri, T., Bellani, G., Confalonieri, A. et al. Neurally adjusted ventilatory assist reduces asynchrony and patient effort in severe acute respiratory distress syndrome patients undergoing extracorporeal membrane oxygenation. Crit Care 15 (Suppl 1), P191 (2011). https://doi.org/10.1186/cc9611

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc9611

Keywords